El pequeño libro del cánnabis. Amanda Siebert

Neuron 81, no. 5 (2014): 1111-1125, ncbi.nlm.nih.gov/pmc/articles/PMC3955008

      9. José Alexandre S. Crippa, Antonio Waldo Zuardi, y Jaime E. C. Hallak, «Uso terapêutico dos canabinoides em psiquiatría». Revista Brasileira de Psiquiatria 32, no. 1 (2010): 556-566, scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000500009&lng=en&nrm=iso&tlng=en

      10. Isaac G. Karniol et al., «Cannabidiol Interferes with the Effects of Δ⁹– Tetrahydrocannabinol in Man», European Journal of Pharmacology 28, no. 1 (1974): 172-177, sciencedirect.com/science/article/pii/0014299974901290?via%3Dihub

      11. A.W. Zuardi et al., «Action of Cannabidiol on the Anxiety and Other Effects Produced by Δ⁹-THC in Normal Subjects», Psychopharmacology 76, no. 3 (1982): 245-250, ncbi.nlm.nih.gov/pubmed/6285406

      12. Christine A. Rabinak et al., «Cannabinoid Modulation of Prefrontal-Limbic Activation during Fear Extinction Learning and Recall in Humans», Neurobiology of Learning and Memory 113 (septiembre 2014): 125-134, ncbi.nlm.nih.gov/pmc/articles/PMC3960373

      13. Stephanie M. Gorka et al., «Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat», International Journal of Neuropsychopharmacology 18, no. 3 (2015): 1-6, ncbi.nlm.nih.gov/pmc/articles/PMC4360235

      14. Edward Wadieh, Lisa Y. Adams, y Tony L. Brown, «Neuropsychiatric Effects of Marijuana», MOJ Addiction Medicine & Therapy 3 (2017): 61-64, medcraveonline.com/MOJAMT/MOJAMT-03-00034.pdf

      15. Esther M. Blessing et al., «Cannabidiol as a Potential Treatment for Anxiety Disorders», Neurotherapeutics 12, no. 4 (octubre 2015): 825-836, ncbi.nlm.nih.gov/pmc/articles/PMC4604171